These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
582 related articles for article (PubMed ID: 15023878)
1. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Mann DL; McMurray JJ; Packer M; Swedberg K; Borer JS; Colucci WS; Djian J; Drexler H; Feldman A; Kober L; Krum H; Liu P; Nieminen M; Tavazzi L; van Veldhuisen DJ; Waldenstrom A; Warren M; Westheim A; Zannad F; Fleming T Circulation; 2004 Apr; 109(13):1594-602. PubMed ID: 15023878 [TBL] [Abstract][Full Text] [Related]
2. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Anker SD; Coats AJ Int J Cardiol; 2002 Dec; 86(2-3):123-30. PubMed ID: 12419548 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Deswal A; Bozkurt B; Seta Y; Parilti-Eiswirth S; Hayes FA; Blosch C; Mann DL Circulation; 1999 Jun; 99(25):3224-6. PubMed ID: 10385494 [TBL] [Abstract][Full Text] [Related]
4. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Bozkurt B; Torre-Amione G; Warren MS; Whitmore J; Soran OZ; Feldman AM; Mann DL Circulation; 2001 Feb; 103(8):1044-7. PubMed ID: 11222463 [TBL] [Abstract][Full Text] [Related]
5. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial. Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236 [TBL] [Abstract][Full Text] [Related]
12. Use of targeted anticytokine treatments in heart failure. Mohler KM; Murray KM; Mann DL; Francis G Circulation; 2000 Aug; 102(9):E65. PubMed ID: 10961980 [No Abstract] [Full Text] [Related]
13. Etanercept treatment for children and adolescents with plaque psoriasis. Paller AS; Siegfried EC; Langley RG; Gottlieb AB; Pariser D; Landells I; Hebert AA; Eichenfield LF; Patel V; Creamer K; Jahreis A; N Engl J Med; 2008 Jan; 358(3):241-51. PubMed ID: 18199863 [TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases. Weisman MH; Paulus HE; Burch FX; Kivitz AJ; Fierer J; Dunn M; Kerr DR; Tsuji W; Baumgartner SW Rheumatology (Oxford); 2007 Jul; 46(7):1122-5. PubMed ID: 17470434 [TBL] [Abstract][Full Text] [Related]
15. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Brandt J; Khariouzov A; Listing J; Haibel H; Sörensen H; Grassnickel L; Rudwaleit M; Sieper J; Braun J Arthritis Rheum; 2003 Jun; 48(6):1667-75. PubMed ID: 12794835 [TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis. Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937 [TBL] [Abstract][Full Text] [Related]
17. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Sankar V; Brennan MT; Kok MR; Leakan RA; Smith JA; Manny J; Baum BJ; Pillemer SR Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223 [TBL] [Abstract][Full Text] [Related]
18. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Papp KA; Tyring S; Lahfa M; Prinz J; Griffiths CE; Nakanishi AM; Zitnik R; van de Kerkhof PC; Melvin L; Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997 [TBL] [Abstract][Full Text] [Related]
19. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476 [TBL] [Abstract][Full Text] [Related]
20. TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Aaron SD; Vandemheen KL; Maltais F; Field SK; Sin DD; Bourbeau J; Marciniuk DD; FitzGerald JM; Nair P; Mallick R Thorax; 2013 Feb; 68(2):142-8. PubMed ID: 23161645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]